MAPK9 and cancer: We here provide evidence that MK3-overexpression or ablation changes signaling through MAPK and SAPK, and has profound effects on proliferative control both in normal and cancer cell lines, positioning MK3 function both up- and down-stream of M/SAPKs, likely as part of regulatory feedback loops.